Home
Antares Pharma

Antares Pharma Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainantarespharma.com

Year Founded1979

Employees51 - 200

Annual Revenue$100M - $200M

Antares Pharma

Antares Pharma (including company regionals)

antarespharma.com

See more website traffic and engagement information

Antares Pharma Revenue up to June 2026 is 100M - 200M

revenue generated by Antares Pharma top domains

Antares Pharma top domains revenue over 3 years

Revenue for Antares Pharma top domains

antarespharma.com100M - 200M

See more with Sales Intelligence

Total visits to Antares Pharma's top domains

Understand Antares Pharma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Antares Pharma's top domains

Analyze Antares Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Antares Pharma's top domains

See how Antares Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Antares Pharma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

vetter-pharma.comCompany NameVetter PharmaEmployees5001 - 10000HQGermany, RavensburgAnnual revenue$500M - $1BTotal visits67KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Antares Pharma

These are the website technologies, by industry, used by Antares Pharma top domains

Payment & Currencies (4)

Euro

Email Services (3)

Microsoft Exchange Online

Widget (3)

reCAPTCHA

Advertising (2)

DoubleClick

More Technologies

7

See all

News & Signals from Antares Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAntarespharma sells assets to Halozyme Therapeutics, Inc..I am a little sad to see Antares sell out to Halozyme.

NewsAntarespharma hires James E Fickenscher as senior vice-president and chief financial officer.New Jersey-based Antares Pharma, which develops self-administered parenteral pharmaceutical products, has named James E Fickenscher senior vice-president and chief financial officer.

NewsAntarespharma had issues with violated the federal securities laws on Apr 13th '22.Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Antares Pharma, Inc. (NASDAQ: ATRS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Halozyme Therapeutics, Inc. (NASDAQ: HALO).